Name,MoA1,MoA,MERS EC50 然,SARS EC50 然,2019-nCoV EC50 然,HCoV-229E EC50 然,EC50,CC50 然 Caco-2,CC50_然 Vero,CC50_然 BHK-21,CC50_然 HUH7,Ref,Unnamed: 13,SMILES
8-(3-chlorostyryl)caffeine,,,,,1.6,,1.6,,,,,https://doi.org/10.1101/2020.04.16.044016,,CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)/C=C/C3=CC(=CC=C3)Cl
adoprazine,"dopamine receptor antagonist, serotonin receptor agonist",,,,18.59,,18.59,75.9,,,,10.21203/rs.3.rs-23951/v1,,C1CN(CCN1CC2=CC(=CN=C2)C3=CC=C(C=C3)F)C4=C5C(=CC=C4)OCCO5
AG7088,,rhinovirus 3Cpro inhibitor,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC2=CC=C(C=C2)F)CC(=O)[C@H](C(C)C)NC(=O)C3=NOC(=C3)C
ai-10-49,,,,,0.19,,0.19,6.58,,,,10.21203/rs.3.rs-23951/v1,,C1=CC2=C(C=C1OC(F)(F)F)NC(=N2)C3=NC=C(C=C3)OCCOCCOC4=CN=C(C=C4)C5=NC6=C(N5)C=C(C=C6)OC(F)(F)F
alisporivir,,,,,3.1,,3.1,>20,,,,10.21203/rs.3.rs-23951/v1,,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(CC)C(=O)[C@@H](C)N(C)C1=O)C(C)C
almitrine,neurotransmitter agonist,,,,1.42,,1.42,102.2,,,,10.21203/rs.3.rs-23951/v1,,Fc1ccc(cc1)C(N2CCN(CC2)c3nc(NCC=C)nc(NCC=C)n3)c4ccc(F)cc4
alprostadil,prostanoid receptor agonist,,,,5.39,,5.39,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O
alvocidib,CDK inhibitor,,,,0.59,,0.59,0.06,,,,10.21203/rs.3.rs-23951/v1,,CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl
amg-9810,,,,,14.97,,14.97,14.22,,,,10.21203/rs.3.rs-23951/v1,,CC(=CCCC1(C=CC2=C(C3=C(C(=C2O1)CC=C(C)C)OC45C6CC(C=C4C3=O)C(C5(OC6(C)C)C/C=C(/C)\C(=O)O)O)O)C)C
amodiaquine,histamine receptor agonist,Antiparasitic agent,6.21,1.27,5.64,,5.64,,>50,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O
amprenavir,HIV protease inhibitor,,,,31.32,,31.32,,>81,,,https://doi.org/10.1101/2020.04.06.026476,,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)c3ccc(N)cc3
amuvatinib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor",,,,0.02,,0.02,0.06,,,,10.21203/rs.3.rs-23951/v1,,S=C(NCc1ccc2OCOc2c1)N3CCN(CC3)c4ncnc5c4oc6ccccc56
anidulafungin,"fungal 1,3-beta-D-glucan synthase inhibitor",,,,4.64,,4.64,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,CCCCCOc1ccc(cc1)c2ccc(cc2)c3ccc(cc3)[14C](=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@@H](O)CN6C(=O)[C@@H](NC4=O)[C@H](C)O)[C@H](O)[C@@H](O)c7ccc(O)cc7)[C@H](C)O
apilimod,,,,,0.023,,0.023,,,,,https://doi.org/10.1101/2020.04.16.044016,,CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4
apixaban,coagulation factor inhibitor,,,,5.91,,5.91,18.07,,,,10.21203/rs.3.rs-23951/v1,,COc1ccc(cc1)n2nc(C(=O)N)c3CCN(C(=O)c23)c4ccc(cc4)N5CCCCC5=O
arbidol,cytochrome P450 inhibitor,,,,10.7,,10.7,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,CCOC(=O)c1c(CSc2ccccc2)n(C)c3cc(Br)c(O)c(CN(C)C)c13
astemizole,histamine receptor antagonist,Neurotransmitter inhibitor (withdrawn),4.88,5.59,1.1,,1.1,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.04.16.044016,COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1
atazanavir,HIV protease inhibitor,,,,9.36,,9.36,,>50,,,https://doi.org/10.1101/2020.04.06.026476,,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc2ccc(cc2)c3ccccn3)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
avasimibe,ACAT inhibitor,,,,3.93,,3.93,13.71,,,,10.21203/rs.3.rs-23951/v1,,CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(cccc2C(C)C)C(C)C)c(c1)C(C)C
avatrombopag,thrombopoietin receptor agonist,,,,5.71,,5.71,20.86,,,,10.21203/rs.3.rs-23951/v1,,OC(=O)C1CCN(CC1)c2ncc(cc2Cl)C(=O)Nc3nc(c4cc(Cl)cs4)c(s3)N5CCN(CC5)C6CCCCC6
azithromycine,,,,,2.12,,2.12,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
bazedoxifene,selective estrogen receptor modulator (SERM),,,,3.44,,3.44,,14.97,,,https://doi.org/10.1101/2020.03.20.999730,,Cc1c(c2ccc(O)cc2)n(Cc3ccc(OCCN4CCCCCC4)cc3)c5ccc(O)cc15
benztropine-mesylate,acetylcholine receptor antagonist,,,,17.79,,17.79,,>50,,,https://doi.org/10.1101/2020.03.25.008482,,CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O
berbamine-hydrochloride,,,,,7.87,,7.87,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)O)OC.Cl
bisindolylmaleimide-ix,PKC inhibitor,PKC inhibitor,inhibition 74% @ 10uM,,,,,,,,,https://aac.asm.org/content/59/2/1088.long,,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N
bp-897,,,,,18.95,,18.95,30.03,,,,10.21203/rs.3.rs-23951/v1,,COC1=CC=CC=C1N2CCN(CC2)CCCCNC(=O)C3=CC4=CC=CC=C4C=C3
brexpiprazole,dopamine receptor partial agonist,,,,16.04,,16.04,50.57,,,,10.21203/rs.3.rs-23951/v1,,O=C1Nc2cc(OCCCCN3CCN(CC3)c4cccc5sccc45)ccc2C=C1
bufalin,,inhibit MERS-CoV entry by blocking clathrin-mediated endocytosis,inhibition > 90% @ 10 nM,,,,,,,,,https://jvi.asm.org/content/89/8/4434.long,,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4(C)[C@H](CC[C@]34O)C5=COC(=O)C=C5
camostat,,,,,0.64,,0.64,>20,,,,10.21203/rs.3.rs-23951/v1,,CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1
carboxyamidotriazole,calcium channel blocker,,,,0.09,,0.09,0.11,,,,10.21203/rs.3.rs-23951/v1,,C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)CN3C(=C(N=N3)C(=O)N)N)Cl)Cl
cbipes,,,,,17.05,,17.05,13.4,,,,10.21203/rs.3.rs-23951/v1,,CCS(=O)(=O)N(CC1=CN=CC=C1)C2=CC=CC(=C2)C3=CC=C(C=C3)C#N
cc-223,,,,,16.78,,16.78,9.49,,,,10.21203/rs.3.rs-23951/v1,,CC(C)(C)C1=CC=C(C=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OCCO3
cepharanthine,NFkB pathway inhibitor,,,,4.47,,4.47,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,COc1ccc2C[C@H]3N(C)CCc4cc(OC)c(Oc5c6OCOc6cc7CCN(C)[C@@H](Cc8ccc(Oc1c2)cc8)c57)cc34
cetylpyridinium,,,,,0.62,,0.62,0.66,,,,10.21203/rs.3.rs-23951/v1,,CCCCCCCCCCCCCCCC[n+]1ccccc1
chlormidazole,fungal lanosterol demethylase inhibitor,,,,1.89,,1.89,0.88,,,,10.21203/rs.3.rs-23951/v1,,Cc1nc2ccccc2n1Cc3ccc(Cl)cc3
chloroquine,antimalarial agent,,3,,1.13,,1.13,,>37.5,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CCN(CC)CCC[C@H](C)Nc1ccnc2cc(Cl)ccc12
chlorphenoxamine-hydrochloride,,Neurotransmitter inhibitor,12.64,20.03,4.03,,4.03,,,,,,https://doi.org/10.1101/2020.03.25.008482,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCN(C)C.Cl
ciclesonide,glucocorticoid receptor agonist,,,,4.33,,4.33,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)C6CCCCC6
clemizole,,,,,23.94,,23.94,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,Clc1ccc(Cn2c(CN3CCCC3)nc4ccccc24)cc1
cloconazole,,,,,18.92,,18.92,33,,,,10.21203/rs.3.rs-23951/v1,,C=C(C1=CC=CC=C1OCC2=CC(=CC=C2)Cl)N3C=CN=C3
clomiphene-citrate,,,,,5.36,,5.36,,15.01,,,https://doi.org/10.1101/2020.03.20.999730,,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
clomipramine,serotonin transporter (SERT) inhibitor,Neurotransmitter inhibitor,9.33,13.23,7.59,,7.59,,>30,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13
cyclosporine,calcineurin inhibitor,calcineurin inhibitor,,,5.82,,5.82,,>50,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.20.999730,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
dapivirine,non-nucleoside reverse transcriptase inhibitor,,,,0.73,,0.73,5,,,,10.21203/rs.3.rs-23951/v1,,Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)[14C]#N)n2)c(C)c1
darunavir,HIV protease inhibitor,,,,46.41,,46.41,,>81,,,https://doi.org/10.1101/2020.04.06.026476,,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)S(=O)(=O)c4ccc(N)cc4
dasatinib,"Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor",ABL1 inhibitor,5.46,2.1,,,3.78,,>10,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4
dcpib,"chloride channel blocker, gap junction modulator, glutamate inhibitor",,,,12.78,,12.78,24.55,,,,10.21203/rs.3.rs-23951/v1,,CCCCC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCCCC(=O)O)C3CCCC3
digitoxin,ATPase inhibitor,,,,0.23,,0.23,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C
digoxin,ATPase inhibitor,,,,0.19,,0.19,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C
dihydrogambogic-acid,,,,,13.37,,13.37,,9.85,,,https://doi.org/10.1101/2020.03.20.999730,,CC(=CCCC1(C=CC2=C(C3=C(C(=C2O1)CC=C(C)C)OC45C6CC(C=C4C3=O)C(C5(OC6(C)C)C/C=C(/C)\C(=O)O)O)O)C)C
disulfiram,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPV agonist",MERS-CoV PL-pro inhibitor,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CCN(CC)C(=S)SSC(=S)N(CC)CC
dolutegravir,HIV integrase inhibitor,,,,22.04,,22.04,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O
droloxifene,selective estrogen receptor modulator (SERM),,,,6.6,,6.6,,15.82,,,https://doi.org/10.1101/2020.03.20.999730,,CC\C(=C(\c1ccc(OCCN(C)C)cc1)/c2cccc(O)c2)\c3ccccc3
dronedarone,,,,,3.92,,3.92,,8.75,,,https://doi.org/10.1101/2020.03.20.999730,,CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c(CCCC)oc3ccc(NS(=O)(=O)C)cc23
drotaverine,phosphodiesterase inhibitor,,,,6.07,,6.07,9,,,,10.21203/rs.3.rs-23951/v1,,CCOc1ccc(\C=C\2/NCCc3cc(OCC)c(OCC)cc23)cc1OCC
E-64-D,,"Cathepsin inhibitor, block virus entry",1.27,0.76,,,1.015,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C
ebastine,histamine receptor antagonist,,,,6.92,,6.92,,15.42,,,https://doi.org/10.1101/2020.03.20.999730,,CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4
elopiprazole,,,,,1.1,,1.1,,,,,https://doi.org/10.1101/2020.04.16.044016,,Fc1ccc(cc1)c2ccc(CN3CCN(CC3)c4cccc5ccoc45)[nH]2
eltrombopag,thrombopoietin receptor agonist,,,,8.27,,8.27,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,CC1=NN(C(=O)/C/1=N\Nc2cccc(c2O)c3cccc(c3)C(=O)O)c4ccc(C)c(C)c4
emetine,protein synthesis inhibitor,"Inhibits RNA, DNA and protein synthesis",0.34,,0.46,,0.46,,56.46,3.08,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://www.sciencedirect.com/science/article/pii/S016635422030200X,Cl.Cl.CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]4NCCc5cc(OC)c(OC)cc45
ethaverine,calcium channel blocker,,,,0.64,,0.64,11.04,,,,10.21203/rs.3.rs-23951/v1,,CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC
etifoxine,,,,,20.64,,20.64,43.53,,,,10.21203/rs.3.rs-23951/v1,,CCNC1=Nc2ccc(Cl)cc2C(C)(O1)c3ccccc3
F2124-0890,,PLproenzymes inhibitor,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,C1=NC(=C2C(=N1)N=C(N2)C(F)(F)F)N
flunarizine,calcium channel blocker,,,,19.05,,19.05,136.76,,,,10.21203/rs.3.rs-23951/v1,,Fc1ccc(cc1)C(N2CCN(C\C=C\c3ccccc3)CC2)c4ccc(F)cc4
fluphenazine,dopamine receptor antagonist,Neurotransmitter inhibitor,5.86,21.43,8.98,,8.98,,20.02,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1
fluspirilene,dopamine receptor antagonist,Neurotransmitter inhibitor,7.47,5.96,5.32,,5.32,,30.33,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,Fc1ccc(cc1)C(CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)c5ccc(F)cc5
GC376,,3CL-pro inhibitor,0.9,,,,0.9,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CC(C)C[C@@H](C(=O)N[C@@H](CC1CCNC1=O)C(O)S(=O)(=O)[O-])NC(=O)OCC2=CC=CC=C2.[Na+]
gilteritinib,FLT3 inhibitor,,,,6.76,,6.76,,37.16,,,https://doi.org/10.1101/2020.03.20.999730,,CCc1nc(C(=O)N)c(Nc2ccc(N3CCC(CC3)N4CCN(C)CC4)c(OC)c2)nc1NC5CCOCC5
gsk2606414,,,,,0.25,,0.25,70.35,,,,10.21203/rs.3.rs-23951/v1,,Cn1cc(c2ccc3N(CCc3c2)C(=O)Cc4cccc(c4)C(F)(F)F)c5c(N)ncnc15
GW-5074,,Raf inhibitor,inhibition 52% @ 10uM,,,,,,,,,https://aac.asm.org/content/59/2/1088.long,,C1=CC2=C(C=C1I)/C(=C/C3=CC(=C(C(=C3)Br)O)Br)/C(=O)N2
hanfangchin-a,,,,,1.1,,1.1,,,,,https://doi.org/10.1101/2020.04.16.044016,,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C4)OC)OC5=CC=C(CC6C7=CC(=C(C=C7CCN6C)OC)O3)C=C5)OC)OC
harringtonine,protein synthesis inhibitor,,,,19,,19,0.07,,,,10.21203/rs.3.rs-23951/v1,,CC(C)(CC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
hematoporphyrin,,,,,1.85,,1.85,160.08,,,,10.21203/rs.3.rs-23951/v1,,CC(O)C1=C(C)c2cc3[nH]c(cc4nc(cc5nc(cc1[nH]2)c(C)c5CCC(=O)O)c(CCC(=O)O)c4C)c(C)c3C(C)O
hexachlorophene,potassium channel activator,,,,0.9,,0.9,,19.3,,,https://doi.org/10.1101/2020.03.20.999730,,Oc1c(Cl)cc(Cl)c(Cl)c1Cc2c(O)c(Cl)cc(Cl)c2Cl
hexamethyleneamiloride,,reduces the ion channel activity of E in virus,,,,1.34,1.34,,,,,https://www.sciencedirect.com/science/article/pii/S004268220600359X,,C1CCCN(CC1)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N
homoharringtonine,protein synthesis inhibitor,,,,4.71,,4.71,1.72,59.75,,,10.21203/rs.3.rs-23951/v1,https://www.sciencedirect.com/science/article/pii/S016635422030200X,COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN5CCC[C@]25C=C1OC
hydroxychloroquine,antimalarial agent,,,,11.17,,11.17,,>40,,,https://doi.org/10.1101/2020.03.25.008482,,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
hydroxyprogesterone-acetate,progesterone receptor agonist,,,,6.3,,6.3,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)OC(=O)C
imatinib,"Bcr-Abl kinase inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor",ABL1 inhibitor,17.68,9.82,5.32,,5.32,,>30.86,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1
ipag,,,,,5.96,,5.96,11.48,,,,10.21203/rs.3.rs-23951/v1,,C1C2CC3CC1CC(C2)C3N=C(N)NC4=CC=C(C=C4)I
isoosajin,,,,,3.22,,3.22,,9.89,,,https://doi.org/10.1101/2020.03.20.999730,,CC1(CCC2=C3C(=C4C(=C2O1)C(=O)C(=CO4)C5=CC=C(C=C5)O)C=CC(O3)(C)C)C
isopomiferin,,,,,4.51,,4.51,,14.25,,,https://doi.org/10.1101/2020.03.20.999730,,CC1(CCC2=C3C(=C4C(=C2O1)C(=O)C(=CO4)C5=CC(=C(C=C5)O)O)C=CC(O3)(C)C)C
ivacaftor,CFTR channel potentiator,,,,6.57,,6.57,,12.47,,,https://doi.org/10.1101/2020.03.20.999730,,CC(C)(C)c1cc(c(NC(=O)C2=CNc3ccccc3C2=O)cc1O)C(C)(C)C
ivermectin,benzodiazepine receptor agonist,,,,2,,2,,3.5~10,,,https://www.sciencedirect.com/science/article/pii/S0166354220302011,,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C\C=C(/C)\[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C\6/CO[C@@H]7[C@H](O)C(=C[C@@H](C(=O)O3)[C@]67O)C)O2.CO[C@H]8C[C@H](O[C@H]9[C@H](C)O[C@H](C[C@@H]9OC)O[C@H]%10[C@@H](C)\C=C\C=C\%11/CO[C@@H]%12[C@H](O)C(=C[C@@H](C(=O)O[C@H]%13C[C@@H](C\C=C\%10/C)O[C@@]%14(CC[C@H](C)[C@H](O%14)C(C)C)C%13)[C@]%11%12O)C)O[C@@H](C)[C@@H]8O
jte-013,,,,,5.97,,5.97,16.45,,,,10.21203/rs.3.rs-23951/v1,,CC1=NN(C2=C1C(=CC(=N2)NNC(=O)NC3=CC(=NC(=C3)Cl)Cl)C(C)C)C
ketoconazole,sterol demethylase inhibitor,,,,2.36,,2.36,28.62,,,,10.21203/rs.3.rs-23951/v1,,CC(=O)N1CCN(CC1)c2ccc(OCC3COC(Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2
kw-8232,,,,,1.2,,1.2,,,,,https://doi.org/10.1101/2020.04.16.044016,,CN(C)CCN1C2=CC=CC=C2C(=C1C(=O)N3CCN(CC3)C4=CC=CC=C4Cl)C(C5=CC=C(C=C5)O)C6=CC=C(C=C6)OS(=O)(=O)C
lde225,,,,,10.67,,10.67,2.26,,,,10.21203/rs.3.rs-23951/v1,,C[C@@H]1CN(C[C@H](C)O1)c2ccc(NC(=O)c3cccc(c3C)c4ccc(OC(F)(F)F)cc4)cn2
ldk378,,,,,2.86,,2.86,,6.84,,,https://doi.org/10.1101/2020.03.20.999730,,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl
LGK-974,porcupine inhibitor,,,,3.27,,3.27,7.61,,,,10.21203/rs.3.rs-23951/v1,,CC1=CC(=CN=C1C2=CC(=NC=C2)C)CC(=O)NC3=NC=C(C=C3)C4=NC=CN=C4
lidoflazine,calcium channel blocker,,,,17.39,,17.39,31.91,,,,10.21203/rs.3.rs-23951/v1,,Cc1cccc(C)c1NC(=O)CN2CCN(CCCC(c3ccc(F)cc3)c4ccc(F)cc4)CC2
LJ001,,induce changes in the properties of lipid membranes and prevent fusion between viral and target cell membranes,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,C=CCN1C(/C(=C/C2=CC=C(O2)C3=CC=CC=C3)/SC1=S)O
lonafarnib,farnesyltransferase inhibitor,,,,5.68,,5.68,10.71,,,,10.21203/rs.3.rs-23951/v1,,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]3c4ncc(Br)cc4CCc5cc(Cl)cc(Br)c35)CC1
loperamide,opioid receptor agonist,antidiarrheal opioid receptor agonist,4.8,5.9,9.27,,9.27,,29.26,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.20.999730,CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4
lopinavir,HIV protease inhibitor,HIV-1 inhibitor,8,24.4,5.73,,5.73,,>50,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.04.06.026476,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)Cc4ccccc4
loratadine,histamine receptor antagonist,,,,15.13,,15.13,28.33,,,,10.21203/rs.3.rs-23951/v1,,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc4cccnc24)CC1
loteprednol,,,,,17.92,,17.92,49.03,,,,10.21203/rs.3.rs-23951/v1,,CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl
lusutrombopag,,,,,3.78,,3.78,,14.61,,,https://doi.org/10.1101/2020.03.20.999730,,CCCCCCO[C@@H](C)c1cccc(c1OC)c2csc(NC(=O)c3cc(Cl)c(\C=C(/C)\C(=O)O)c(Cl)c3)n2
ly2228820,p38 MAPK inhibitor,,,,0.87,,0.87,56.2,,,,10.21203/rs.3.rs-23951/v1,,CC(C)(C)Cn1c(N)nc2ccc(nc12)c3[nH]c(nc3c4ccc(F)cc4)C(C)(C)C
Lycorine,,"Inhibits cell division, antineoplastic, antiviral",1.63,,,,1.63,,,3.14,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)O)OCO4
mdl-28170,,,,,0.22,,0.22,,,,,https://doi.org/10.1101/2020.04.16.044016,,CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2
mefloquine,"adenosine receptor antagonist, hemoglobin antagonist",Antiparasitic agent,7.41,15.55,8.06,,8.06,,18.53,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,O[C@@H]([C@H]1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F
mequitazine,,,,,7.28,,7.28,,27.34,,,https://doi.org/10.1101/2020.03.20.999730,,C(N1c2ccccc2Sc3ccccc13)C45CCN(CC4)CC5
methyl-_-cyclodextrin,,inhibit the virus replication via an aveolin-1/caveolin-1-dependent endocytosis entry,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CO[C@@H]1[C@H]([C@@H]2O[C@@H]([C@@H]1O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@@H]7[C@@H]([C@H]([C@H](O2)[C@H](O7)CO)O)O)O)O)O)O)O)O)O)O)CO)O
methylene-blue,,,,,2.03,,2.03,7.25,,,,10.21203/rs.3.rs-23951/v1,,CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-]
MG-132,proteasome inhibitor,cys-protease m-calpain inhibition,,,,,,,,,,https://jvi.asm.org/content/86/18/10112.long,,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1
mibampator,glutamate receptor modulator,,,,3.28,,3.28,8.66,,,,10.21203/rs.3.rs-23951/v1,,CC(C)S(=O)(=O)NC[C@H](C)c1ccc(cc1)c2ccc(CCNS(=O)(=O)C)cc2
monensin,bacterial permeability inducer,Antibacterial,3.27,,,,3.27,,,>20,,https://jvi.asm.org/content/93/12/e00023-19,,CC[C@]1(CC[C@@H](O1)[C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@H](O3)[C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O2)[C@@H]4O[C@H](C[C@@H]4C)[C@H]5O[C@@](O)(CO)[C@H](C)C[C@@H]5C
mycophenolate-mofetil,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","Immune suppressant, antineoplastic, antiviral",1.54,,,,1.54,,,3.17,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O
mycophenolic-acid,"dehydrogenase inhibitor, inositol monophosphatase inhibitor","Immune suppressant, antineoplastic, antiviral",1.95,,,,1.95,,,3.21,,https://jvi.asm.org/content/93/12/e00023-19,,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O
Nafamostat,,,,,22.5; 0.04,,,>20,,,,https://www.nature.com/articles/s41422-020-0282-0,10.21203/rs.3.rs-23951/v1,C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
nelfinavir,HIV protease inhibitor,HIC-1 protease inhibitor,,,1.13,,1.13,,,,,https://doi.org/10.1101/2020.04.06.026476,,Cc1c(O)cccc1C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
niclosamide,"DNA replication inhibitor, STAT inhibitor",,,2,0.28,,0.28,,>50,,,https://aac.asm.org/content/48/7/2693.long,https://doi.org/10.1101/2020.03.20.999730,Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-]
nitazoxanide,pyruvate ferredoxin oxidoreductase inhibitor,"antiprotozoal, type I IFN inducer",,,2.12,,2.12,,>35.53,,,https://www.nature.com/articles/s41422-020-0282-0,,CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-]
nsc319726,p53 activator,,,,<0.02,,0.02,<0.02,,,,10.21203/rs.3.rs-23951/v1,,C/C(=N\NC(=S)N1CCC1)/C2=CC=CC=N2
nystatin,,inhibit the virus replication via an aveolin-1/caveolin-1-dependent endocytosis entry,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@H]1C)O2)C(=O)O
octenidine,membrane integrity inhibitor,,,,1.65,,1.65,2.4,,,,10.21203/rs.3.rs-23951/v1,,CCCCCCCCN=C1C=CN(CCCCCCCCCCN2C=CC(=NCCCCCCCC)C=C2)C=C1
omeprazole,ATPase inhibitor,,,,17.06,,17.06,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,COc1ccc2[nH]c(nc2c1)[S+]([O-])Cc3ncc(C)c(OC)c3C
ono-5334,,,,,0.5,,0.5,,,,,https://doi.org/10.1101/2020.04.16.044016,,C[C@@H]1CS/C(=N\NC(=O)C(=O)[C@H](C2CCOCC2)NC(=O)C3CCCCCC3)/N1C
opipramol,sigma receptor agonist,,,,5.05,,5.05,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,OCCN1CCN(CCCN2c3ccccc3C=Cc4ccccc24)CC1
osajin,,,,,3.87,,3.87,,11.44,,,https://doi.org/10.1101/2020.03.20.999730,,CC(=CCC1=C2C(=C3C(=C1O)C(=O)C(=CO3)C4=CC=C(C=C4)O)C=CC(O2)(C)C)C
osimertinib,EGFR inhibitor,,,,3.26,,3.26,,13.23,,,https://doi.org/10.1101/2020.03.20.999730,,COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc2nccc(n2)c3cn(C)c4ccccc34
ouabain,ATPase inhibitor,inhibit MERS-CoV entry by blocking clathrin-mediated endocytosis,inhibition 70% @ 50 nM,,<0.097,,0.097,,>50,,,https://jvi.asm.org/content/89/8/4434.long,https://doi.org/10.1101/2020.03.20.999730,O.O.O.O.O.O.O.O.C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
oxiconazole,bacterial cell wall synthesis inhibitor,,,,20.82,,20.82,26.36,,,,10.21203/rs.3.rs-23951/v1,,Clc1ccc(CO\N=C(/Cn2ccnc2)\c3ccc(Cl)cc3Cl)c(Cl)c1
oxprenolol,adrenergic receptor antagonist,,,,20.22,,20.22,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,CC(C)NCC(O)COc1ccccc1OCC=C
oxyclozanide,,,,,3.71,,3.71,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,Oc1c(Cl)cc(Cl)cc1NC(=O)c2c(O)c(Cl)cc(Cl)c2Cl
papaverine,phosphodiesterase inhibitor,,,,1.1,,1.1,4.49,,,,10.21203/rs.3.rs-23951/v1,,Cl.COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC
penfluridol,T-type calcium channel blocker,,,,5.01,,5.01,,8.77,,,https://doi.org/10.1101/2020.03.20.999730,,OC1(CCN(CCCC(c2ccc(F)cc2)c3ccc(F)cc3)CC1)c4ccc(Cl)c(c4)C(F)(F)F
perhexiline,carnitine palmitoyltransferase inhibitor,,,,6.38,,6.38,,8.67,,,https://doi.org/10.1101/2020.03.20.999730,,C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3
pevonedistat,nedd activating enzyme inhibitor,,,,0.63,,0.63,222.44,,,,10.21203/rs.3.rs-23951/v1,,NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n2ccc3c(N[C@H]4CCc5ccccc45)ncnc23
pexidartinib,tyrosine kinase inhibitor,,,,5.43,,5.43,41.53,,,,10.21203/rs.3.rs-23951/v1,,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1
pf-670462,,,,,19.23,,19.23,8.24,,,,10.21203/rs.3.rs-23951/v1,,C1CCC(CC1)N2C=NC(=C2C3=NC(=NC=C3)N)C4=CC=C(C=C4)F.Cl.Cl
ph-797804,,,,,18.85,,18.85,19.97,,,,10.21203/rs.3.rs-23951/v1,,CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C
phenazopyridine,local anesthetic,Analgesic,1.93,,28,,28,,>50,>20,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.20.999730,Nc1ccc(\N=N\c2ccccc2)c(N)n1
polidocanol,local anesthetic,,,,0.22,,0.22,10.3,,,,10.21203/rs.3.rs-23951/v1,,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
posaconazole,sterol demethylase inhibitor,,,,1.61,,1.61,14.64,,,,10.21203/rs.3.rs-23951/v1,,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(OC[C@@H]5CO[C@](Cn6cncn6)(C5)c7ccc(F)cc7F)cc4
promethazine,histamine receptor antagonist,Neurotransmitter inhibitor,11.8,7.54,10.44,,10.44,,>42.59,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,Cl.CC(CN1c2ccccc2Sc3ccccc13)N(C)C
proscillaridin,,,,,2.04,,2.04,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CCC3=C2)C6=COC(=O)C=C6)[C@H](O)[C@H](O)[C@H]1O
pyronaridine,antimalarial agent,,,,31.75,,31.75,,,,,https://doi.org/10.1101/2020.03.20.999730,,COc1ccc2nc3cc(Cl)ccc3c(Nc4cc(CN5CCCC5)c(O)c(CN6CCCC6)c4)c2n1
pyrvinium-pamoate,,Anthelmintic,1.84,,,,1.84,,,19.91,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CC1=CC(=C(N1C2=CC=CC=C2)C)/C=C/C3=[N+](C4=C(C=C(C=C4)N(C)C)C=C3)C.CC1=CC(=C(N1C2=CC=CC=C2)C)/C=C/C3=[N+](C4=C(C=C(C=C4)N(C)C)C=C3)C.C1=CC=C2C(=C(C(=CC2=C1)C(=O)O)[O-])CC3=C(C(=CC4=CC=CC=C34)C(=O)O)[O-]
quinidine,sodium channel blocker,,,,5.11,,5.11,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1
ravuconazole,sterol demethylase inhibitor,,,,2.76,,2.76,12.75,,,,10.21203/rs.3.rs-23951/v1,,C[C@@H](c1nc(cs1)c2ccc(cc2)C#N)[C@](O)(Cn3cncn3)c4ccc(F)cc4F
regorafenib,"FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor",,,,1.67,,1.67,0.97,,,,10.21203/rs.3.rs-23951/v1,,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1
remdesivir,,,,,0.77,,0.77,,>50,,,https://www.nature.com/articles/s41422-020-0282-0,,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
ritonavir,HIV protease inhibitor,,24.9,,8.63,,8.63,,71.44,,,https://www.nature.com/articles/s41467-019-13940-6,https://doi.org/10.1101/2020.04.06.026476,CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)Cc4ccccc4
salinomycin,,,,,0.24,,0.24,,>50,,,https://doi.org/10.1101/2020.03.20.999730,,CC[C@H]([C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)C(=O)O
saquinavir,HIV protease inhibitor,,,,8.83,,8.83,,44.43,,,https://doi.org/10.1101/2020.04.06.026476,,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4
saracatinib,src inhibitor,Src family of tyrosine kinases inhibitor,2.9,2.4,,,2.65,,,,>50,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CN1CCN(CCOc2cc(OC3CCOCC3)c4c(Nc5c(Cl)ccc6OCOc56)ncnc4c2)CC1
SB-203580,p38 MAPK inhibitor,p38 MAPK inhibitor,inhibition 45% @ 10uM,,,,,,,,,https://aac.asm.org/content/59/2/1088.long,,CS(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F
sb-612111,,,,,0.77,,0.77,3.67,,,,10.21203/rs.3.rs-23951/v1,,CC1=C2CC[C@@H](C[C@@H](C2=CC=C1)O)CN3CCC(CC3)C4=C(C=CC=C4Cl)Cl
sdz-62-434,,,,,0.75,,0.75,,,,,https://doi.org/10.1101/2020.04.16.044016,,C1CCN(CC1)C2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35.Cl.Cl
selumetinib,MEK inhibitor,"MEK1, ERK1/2 inhibitor",inhibition >= 95% @ 10uM,,,,,,,,,https://aac.asm.org/content/59/2/1088.long,,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO
silvestrol,,Virus DEAD-box RNA helicase eIF4A inhibitor,,,,,,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CO[C@@H]1OC[C@@H](O[C@H]1Oc2cc(OC)c3c(O[C@]4([C@@H]([C@H]([C@@H](O)[C@@]34O)C(=O)OC)c5ccccc5)c6ccc(OC)cc6)c2)[C@H](O)CO
sirolimus,mTOR inhibitor,MTOR inhibitor,inhibition 61% @ 10uM,,,,,,,,,https://aac.asm.org/content/59/2/1088.long,,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1O
sl-11128,,,,,0.25,,0.25,,,,,https://doi.org/10.1101/2020.04.16.044016,,CCNC/C=C\CNCCCCNCCCCNC/C=C\CNCC
sorafenib,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor",,,,1.55,,1.55,1.17,,,,10.21203/rs.3.rs-23951/v1,,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1
sulfadoxine,dihydropteroate synthase inhibitor,,,,35.37,,35.37,,>40,,,https://doi.org/10.1101/2020.04.03.023846,,COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC
tamoxifen,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)",Estrogen receptor inhibitor,10.11,92.88,8.98,,8.98,,37.96,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,CC\C(=C(/c1ccccc1)\c2ccc(OCCN(C)C)cc2)\c3ccccc3
terconazole,sterol demethylase inhibitor,Sterol metabolism inhibitor,12.2,15.32,16.14,,16.14,,41.46,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,CC(C)N1CCN(CC1)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c5ccc(Cl)cc5Cl)cc2
tetrandrine,calcium channel blocker,,,,3,,3,,14.92,,,https://doi.org/10.1101/2020.03.20.999730,,CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC
thiethylperazine,dopamine receptor antagonist,,,,8.02,,8.02,,18.37,,,https://doi.org/10.1101/2020.03.25.008482,,CCSc1ccc2Sc3ccccc3N(CCCN4CCN(C)CC4)c2c1
thimerosal,,,,,1.69,,1.69,13.52,,,,10.21203/rs.3.rs-23951/v1,,CC[Hg]SC1=CC=CC=C1C(=O)[O-].[Na+]
thioguanosine,,,,,0.78,,0.78,0.63,,,,10.21203/rs.3.rs-23951/v1,,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC(=NC2=S)N
thioridazine,dopamine receptor antagonist,,,,6.69,,6.69,,15.96,,,https://doi.org/10.1101/2020.03.20.999730,,CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1
thiothixene,dopamine receptor antagonist,Neurotransmitter inhibitor,9.29,5.31,,,7.3,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CN(C)S(=O)(=O)c1ccc2Sc3ccccc3\C(=C\CCN4CCN(C)CC4)\c2c1
tilorone,interferon inducer,,,,4.09,,4.09,,19.67,,,https://doi.org/10.1101/2020.03.20.999730,,CCN(CC)CCOc1ccc2c(c1)C(=O)c3cc(OCCN(CC)CC)ccc23
tipranavir,HIV protease inhibitor,,,,13.34,,13.34,,76.8,,,https://doi.org/10.1101/2020.04.06.026476,,CCC[C@@]1(CCc2ccccc2)CC(=C([C@H](CC)c3cccc(NS(=O)(=O)c4ccc(cn4)C(F)(F)F)c3)C(=O)O1)O
toremifene,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)",Estrogen receptor inhibitor,12.91,11.96,11.3,,11.3,,10.11,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,https://doi.org/10.1101/2020.03.25.008482,CN(C)CCOc1ccc(cc1)\C(=C(\CCCl)/c2ccccc2)\c3ccccc3
trametinib,MEK inhibitor,MEK1/2 inhibitor,inhibition >= 95% @ 10uM,,,,,,,,,https://aac.asm.org/content/59/2/1088.long,,CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1Nc4ccc(I)cc4F)c5cccc(NC(=O)C)c5)C
triflupromazine,dopamine receptor antagonist,Neurotransmitter inhibitor,5.75,6.39,,,6.07,,,,,https://www.sciencedirect.com/science/article/pii/S1359644620300416,,CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(F)(F)F
triparanol,,,,,6.41,,6.41,,14.73,,,https://doi.org/10.1101/2020.03.25.008482,,CCN(CC)CCOc1ccc(cc1)C(O)(Cc2ccc(Cl)cc2)c3ccc(C)cc3
tyrphostin,,,,,0.2,,0.2,1.36,,,,10.21203/rs.3.rs-23951/v1,,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Cl)OC
U-0126,,MEK1/2 inhibitor,inhibition 51% @ 10uM,,,,,,,,,https://aac.asm.org/content/59/2/1088.long,,C1=CC=C(C(=C1)N)S/C(=C(/C(=C(/SC2=CC=CC=C2N)\N)/C#N)\C#N)/N
vatalanib,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor",,,,18.27,,18.27,64.18,,,,10.21203/rs.3.rs-23951/v1,,Clc1ccc(Nc2nnc(Cc3ccncc3)c4ccccc24)cc1
vby-825,,,,,0.3,,0.3,,,,,https://doi.org/10.1101/2020.04.16.044016,,CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](C3=CC=C(C=C3)F)C(F)(F)F
VLX600,ubiquitin C-terminal hydrolase inhibitor,,,,0.24,,0.24,0.06,,,,10.21203/rs.3.rs-23951/v1,,CC1=C2C(=CC=C1)C3=C(N2)N=C(N=N3)N/N=C(\C)/C4=CC=CC=N4
z-lvg-chn2,,,,,0.19,,0.19,,,,,https://doi.org/10.1101/2020.04.16.044016,,CC(C)C[C@@H](C(=O)NC(=O)[C@H](C(C)C)NCC(=O)C=[N+]=[N-])NC(=O)OCC1=CC=CC=C1
ZK-93423,benzodiazepine receptor agonist,,,,1.34,,1.34,0.91,,,,10.21203/rs.3.rs-23951/v1,,CCOC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC(=C3)OCC4=CC=CC=C4